Cilostazol [cilostazol]
topical
14
- Terms
-
Cilozek
Claudienne
Noclaud
Pladizol
-
6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone
OPC 13013
OPC-13013
Pletal
Persistent link
https://www.medvik.cz/link/D000077407
Definition
A quinoline and tetrazole derivative that acts as a phosphodiesterase type 3 inhibitor, with anti-platelet and vasodilating activity. It is used in the treatment of PERIPHERAL VASCULAR DISEASES; ISCHEMIC HEART DISEASE; and in the prevention of stroke.
- DUI
- D000077407 MeSH Browser
- CUI
- M0132637
- RN
- N7Z035406B
- CAS
- 2(1H)-Quinolinone, 6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-
- History note
- 2019 (1985)
- Public note
- 2019; CILOSTAZOL was indexed under TETRAZOLES 1985-2018
Allowable subheadings
- AD
- administration & dosage 0
- AE
- adverse effects 0
- AG
- agonists 0
- AA
- analogs & derivatives 0
- AN
- analysis 0
- AI
- antagonists & inhibitors 0
- BL
- blood 0
- CF
- cerebrospinal fluid 0
- CS
- chemical synthesis 0
- CH
- chemistry 0
- CL
- classification 0
- EC
- economics 0
- HI
- history 0
- IM
- immunology 0
- IP
- isolation & purification 0
- ME
- metabolism 0
- PK
- pharmacokinetics 0
- PD
- pharmacology 1
- PO
- poisoning 0
- RE
- radiation effects 0
- ST
- standards 0
- SD
- supply & distribution 0
- TU
- therapeutic use 0
- TO
- toxicity 0
- UR
- urine 0
...
Occurrences in Medvik records
D
Chemicals and Drugs
D03.383.129.617.264
Cefozopran
D03.633.100.810.200
Ethoxyquin
D03.633.100.810.553
Pyrroloiminoquinones
D03.633.100.810.850
Quipazine